Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir" von Dore, Gregory J., Feld, Jordan J.

Volltext

SCFAs strongly stimulate PYY production in human enteroendocrine cells von Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., Blottiere, H. M.

Volltext

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection von Phetsouphanh, Chansavath, Darley, David R., Wilson, Daniel B., Howe, Annett, Munier, C. Mee Ling, Patel, Sheila K., Juno, Jennifer A., Burrell, Louise M., Kent, Stephen J., Dore, Gregory J., Kelleher, Anthony D., Matthews, Gail V.

Volltext

Hepatitis C virus elimination: laying the foundation for achieving 2030 targets von Dore, Gregory J, Bajis, Sahar

Volltext

Direct-acting antiviral agents for HCV infection affecting people who inject drugs von Grebely, Jason, Hajarizadeh, Behzad, Dore, Gregory J.

Volltext

Recent advances in the analysis of residential electricity consumption and applications of smart meter data von Yildiz, B., Bilbao, J.I., Dore, J., Sproul, A.B.

Volltext

Spatio-temporal patterns of air pollution in China from 2015 to 2018 and implications for health risks von Kuerban, Mireadili, Waili, Yizaitiguli, Fan, Fan, Liu, Ye, Qin, Wei, Dore, Anthony J., Peng, Jingjing, Xu, Wen, Zhang, Fusuo

Volltext

Source apportionment of atmospheric ammonia before, during, and after the 2014 APEC summit in Beijing using stable nitrogen isotope signatures von Chang, Yunhua, Liu, Xuejun, Deng, Congrui, Dore, Anthony J, Zhuang, Guoshun

Volltext

Highlighting new phylogenetic specificities of Crohn's disease microbiota von Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Doré, J., Leclerc, M.

Volltext

Assessing Contributions of Agricultural and Nonagricultural Emissions to Atmospheric Ammonia in a Chinese Megacity von Chang, Yunhua, Zou, Zhong, Zhang, Yanlin, Deng, Congrui, Hu, Jianlin, Shi, Zhihao, Dore, Anthony J, Collett, Jeffrey L

Volltext

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis von Lockart, Ian, Yeo, Malcolm G. H., Hajarizadeh, Behzad, Dore, Gregory J., Danta, Mark, Abe, Kazumichi, Carrat, Fabrice, Lusivika‐Nzinga, Clovis, Degasperi, Elisabetta, Di Marco, Vito, Hou, Jinlin, Howell, Jessica, Janjua, Naveed Z, Wong, Stanley, Kumada, Takashi, Lleo, Ana, Persico, Marcello, Lok, Anna S, Wei, Lai, Yang, Ming, Nabatchikova, Ekaterina, Nguyen, Mindie H, Antonio Pineda, Juan, Reig, María, Shiha, Gamal, Yu, Ming‐Lung, Tsai, Pei‐Chien

Volltext

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) von Leroy, Vincent, Angus, Peter, Bronowicki, Jean‐Pierre, Dore, Gregory J., Hezode, Christophe, Pianko, Stephen, Pol, Stanislas, Stuart, Katherine, Tse, Edmund, McPhee, Fiona, Bhore, Rafia, Jimenez‐Exposito, Maria Jesus, Thompson, Alexander J.

Volltext

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis von Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

Volltext

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection von Zeuzem, Stefan, Foster, Graham R, Wang, Stanley, Asatryan, Armen, Gane, Edward, Feld, Jordan J, Asselah, Tarik, Bourlière, Marc, Ruane, Peter J, Wedemeyer, Heiner, Pol, Stanislas, Flisiak, Robert, Poordad, Fred, Chuang, Wan-Long, Stedman, Catherine A, Flamm, Steven, Kwo, Paul, Dore, Gregory J, Sepulveda-Arzola, Gladys, Roberts, Stuart K, Soto-Malave, Ruth, Kaita, Kelly, Puoti, Massimo, Vierling, John, Tam, Edward, Vargas, Hugo E, Bruck, Rafi, Fuster, Francisco, Paik, Seung-Woon, Felizarta, Franco, Kort, Jens, Fu, Bo, Liu, Ran, Ng, Teresa I, Pilot-Matias, Tami, Lin, Chih-Wei, Trinh, Roger, Mensa, Federico J

Volltext

The changing therapeutic landscape for hepatitis C von Dore, Gregory J

Volltext

The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies von Kahan, Brennan C, Jairath, Vipul, Doré, Caroline J, Morris, Tim P

Volltext

Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression von Thein, Hla‐Hla, Yi, Qilong, Dore, Gregory J., Krahn, Murray D.

Volltext

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies von Micallef, J. M., Kaldor, J. M., Dore, G. J.

Volltext

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis von Hajarizadeh, Behzad, Cunningham, Evan B, Reid, Hannah, Law, Matthew, Dore, Gregory J, Grebely, Jason

Volltext

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy : a meta-analysis von THEIN, Hla-Hla, QILONG YI, DORE, Gregory J, KRAHN, Murray D

Volltext